Display options
Share it on

Biomicrofluidics. 2018 Jan 02;12(1):014102. doi: 10.1063/1.5019728. eCollection 2018 Jan.

Aggressive prostate cancer cell nuclei have reduced stiffness.

Biomicrofluidics

Zeina S Khan, Julianna M Santos, Fazle Hussain

Affiliations

  1. Mechanical Engineering, Texas Tech University, Lubbock, Texas 79409, USA.

PMID: 29333204 PMCID: PMC5750055 DOI: 10.1063/1.5019728

Abstract

It has been hypothesized that highly metastatic cancer cells have softer nuclei and hence would travel faster through confining environments. Our goal was to prove this untested hypothesis for prostate cells. Our nuclear creep experiments using a microfluidic channel with a narrow constriction show that stiffness of aggressive immortalized prostate cancer nuclei is significantly lower than that of immortalized normal cell nuclei and hence can be a convenient malignancy marker. Nuclear stiffness is found to be the highest for cells expressing high levels of lamin A/C but lowest for cells expressing low lamin A/C levels. Decreased chromatin condensation found in softer nuclei suggests that the former can also be a marker for aggressive cancers.

References

  1. Nat Rev Cancer. 2002 Aug;2(8):584-93 - PubMed
  2. Integr Biol (Camb). 2015 Dec;7(12):1534-46 - PubMed
  3. Biophys J. 2007 Mar 1;92(5):1784-91 - PubMed
  4. Nat Nanotechnol. 2007 Dec;2(12):780-3 - PubMed
  5. Nat Rev Cancer. 2011 Jun 24;11(7):512-22 - PubMed
  6. Cancer J. 2000 Jul-Aug;6(4):220-33 - PubMed
  7. J Cell Mol Med. 2009 Jun;13(6):1059-85 - PubMed
  8. Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19494-9 - PubMed
  9. Science. 2013 Aug 30;341(6149):1240104 - PubMed
  10. Carcinogenesis. 2012 Apr;33(4):751-9 - PubMed
  11. Eur J Cancer. 2011 Aug;47(12):1837-45 - PubMed
  12. Lab Invest. 2002 May;82(5):555-62 - PubMed
  13. Curr Opin Cell Biol. 2016 Jun;40:32-40 - PubMed
  14. Nature. 2013 Sep 19;501(7467):328-37 - PubMed
  15. Cancer Lett. 2002 Nov 28;185(2):163-72 - PubMed
  16. Biophys J. 2009 May 20;96(10):4319-25 - PubMed
  17. Curr Protoc Pharmacol. 2012 Mar;Chapter 12:Unit12.8 - PubMed
  18. Br J Dermatol. 2003 Jan;148(1):102-9 - PubMed
  19. J Cell Biol. 2013 Jun 24;201(7):1069-84 - PubMed
  20. J Neurooncol. 2005 Oct;75(1):5-14 - PubMed
  21. Clin Cancer Res. 2004 Mar 15;10(6):2044-51 - PubMed
  22. Gut. 1999 Nov;45(5):723-9 - PubMed
  23. Cell Biochem Funct. 1994 Dec;12(4):267-74 - PubMed
  24. J Biol Chem. 2006 Sep 1;281(35):25768-80 - PubMed
  25. Lab Chip. 2013 Sep 21;13(18):3728-34 - PubMed
  26. Leuk Res. 1990;14(9):815-21 - PubMed
  27. PLoS One. 2016 Jan 14;11(1):e0146244 - PubMed
  28. J Clin Invest. 2004 Feb;113(3):370-8 - PubMed
  29. Cancer Metastasis Rev. 1983;2(3):307-17 - PubMed
  30. Semin Cell Dev Biol. 2009 Oct;20(8):931-41 - PubMed
  31. Biophys J. 2015 Jul 7;109(1):26-34 - PubMed
  32. Biophys J. 2012 Nov 21;103(10 ):2060-70 - PubMed
  33. Nat Commun. 2015 Jun 15;6:7159 - PubMed
  34. Cell. 1996 Feb 9;84(3):371-9 - PubMed
  35. Nat Rev Cancer. 2004 Sep;4(9):677-87 - PubMed
  36. Proc Natl Acad Sci U S A. 2013 Nov 19;110(47):18892-7 - PubMed
  37. Biomed Microdevices. 2009 Jun;11(3):557-64 - PubMed
  38. Proc Natl Acad Sci U S A. 2007 Oct 30;104(44):17494-9 - PubMed
  39. Biophys J. 2008 Sep 15;95(6):3028-35 - PubMed
  40. J Clin Invest. 2004 Feb;113(3):357-69 - PubMed
  41. Cell Mol Bioeng. 2014 Sep 1;7(3):293-306 - PubMed
  42. Proc Natl Acad Sci U S A. 2013 May 7;110(19):7580-5 - PubMed
  43. Biochem Soc Trans. 2008 Dec;36(Pt 6):1350-3 - PubMed
  44. PLoS One. 2012;7(10):e46609 - PubMed
  45. Proc Natl Acad Sci U S A. 2006 Jul 5;103(27):10271-6 - PubMed
  46. Cancer Res. 1991 Jan 15;51(2):581-6 - PubMed
  47. Lab Chip. 2012 Oct 7;12(19):3774-8 - PubMed
  48. Nat Rev Cancer. 2005 Sep;5(9):735-43 - PubMed
  49. Biochem Biophys Res Commun. 2002 Mar 8;291(4):1031-7 - PubMed
  50. Biomicrofluidics. 2016 Mar 15;10 (2):021102 - PubMed
  51. J Cell Biol. 2014 Mar 3;204(5):669-82 - PubMed
  52. Radiology. 2008 Mar;246(3):734-41 - PubMed
  53. Phys Biol. 2013 Dec;10(6):065002 - PubMed
  54. Micron. 2012 Dec;43(12):1259-66 - PubMed
  55. Chin J Cancer. 2011 Jun;30(6):415-25 - PubMed
  56. Analyst. 2008 Nov;133(11):1498-500 - PubMed
  57. Prostate. 2002 Apr 1;51(1):10-20 - PubMed
  58. Br J Cancer. 2001 Feb;84(4):512-9 - PubMed
  59. J Biomech. 2002 Feb;35(2):177-87 - PubMed
  60. Am J Physiol Cell Physiol. 2016 Oct 1;311(4):C547-C558 - PubMed
  61. Biomech Model Mechanobiol. 2010 Oct;9(5):563-72 - PubMed
  62. Science. 2016 Apr 15;352(6283):353-8 - PubMed
  63. Proc Natl Acad Sci U S A. 2007 Oct 2;104(40):15619-24 - PubMed
  64. Biochem Soc Trans. 2010 Feb;38(Pt 1):297-300 - PubMed
  65. Nat Nanotechnol. 2012 Nov;7(11):757-65 - PubMed
  66. J Biol Chem. 2013 Mar 22;288(12):8610-8 - PubMed
  67. Am J Pathol. 1993 Jul;143(1):211-20 - PubMed
  68. Acta Biomater. 2007 Jul;3(4):413-38 - PubMed
  69. Cancer Res. 1983 Apr;43(4):1809-18 - PubMed
  70. FASEB J. 2014 Sep;28(9):3906-18 - PubMed
  71. Biochim Biophys Acta. 2012 Jul;1820(7):1111-20 - PubMed
  72. Biophys J. 2005 Oct;89(4):2855-64 - PubMed
  73. J Cell Mol Med. 2008 Jan-Feb;12(1):209-18 - PubMed
  74. J Biomech Eng. 1988 Aug;110(3):190-9 - PubMed
  75. J Cell Sci. 2004 Sep 15;117(Pt 20):4779-86 - PubMed
  76. Bioessays. 2008 Mar;30(3):226-36 - PubMed
  77. Nat Rev Cancer. 2012 Feb 16;12(3):196-209 - PubMed
  78. Br J Dermatol. 2002 Nov;147(5):853-8 - PubMed
  79. Cell Mol Bioeng. 2014 Dec 1;7(4):544-551 - PubMed
  80. Proc Natl Acad Sci U S A. 2012 May 15;109(20):7630-5 - PubMed
  81. Methods. 2007 Feb;41(2):158-67 - PubMed
  82. Curr Opin Cell Biol. 2011 Feb;23(1):55-64 - PubMed

Publication Types